Grabar Law Office Investigates Claims on Behalf of Long-term Shareholders of Adapthealth Corp. (AHCO) as Securities Fraud Class Case Heads to Settlement Mediation

Philadelphia, Pennsylvania--(Newsfile Corp. - July 2, 2025) - A federal securities fraud class action alleging that AdaptHealth Corp. (NASDAQ: AHCO), and certain of its officers failed to make proper disclosures to investors, has been stayed pending settlement mediation.

AdaptHealth shareholders who have continuously held AdaptHealth shares since prior to January 5, 2021 can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. Learn more or join by clicking https://grabarlaw.com/the-latest/adapthealth-shareholder-investigation/, contact Joshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085.

WHY: A federal securities fraud class action against AdaptHealth Corp. (NASDAQ: AHCO) and certain of its offcires has been stayed pending settlement mediation. The underlying complaint alleges that AdaptHealth, via certain of its senior executives, orchestrated a scheme to overcharge CMS and other insurance providers by submitting improper billing codes for diabetes equipment. The Complaint further alleges that to facilitate this scheme, AdaptHealth and certain of its senior executives made numerous false and misleading statements to investors during the Class Period, and that as a result of these misrepresentations, AdaptHealth common stock traded at artificially inflated prices.

On May 28, 2025, the parties in the class action informed the Court that "Lead Plaintiffs and Defendants have agreed to schedule a mediation."

On June 24, the Court Ordered a stay in the case pending the outcome of mediation proceedings.

WHAT YOU CAN DO NOW: If you are a current AdaptHealth (NASDAQ: AHCO) shareholder who has held AdaptHealth shares since prior to January 5, 2021, you can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award at no cost to you whatsoever. If you would like to learn more about this matter, you are encouraged to visit https://grabarlaw.com/the-latest/adapthealth-shareholder-investigation/, contact us at jgrabar@grabarlaw.com, or call 267-507-6085. $AHCO #AdaptHealth

Attorney Advertising Disclaimer

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/257597